Literature DB >> 29706818

Multiple admissions to the coronary care unit due to falsely elevated cardiac troponin.

Mohamed Ayan1, Zaid Gheith1, Aneesha Ananthula1, Mohsin Salih2, Srikanth Vallurupalli1, Jawahar L Mehta1.   

Abstract

The measurement of cardiac troponin, released from injured cardiomyocytes, is of paramount importance in the diagnosis of acute myocardial infarction. Elevated troponin can be encountered, however, in patients with cardiomyopathy, significant cardiac arrhythmias, vasculitis, right-sided heart strain, critical systemic illnesses, stroke, drug toxicity (such as Adriamycin), poisons (such as snake venoms), renal failure, seizure, and rhabdomyolysis. If the clinical picture is not consistent with any of these causes, a false-positive result should be considered. We herein describe a 94-year-old man with a prior history of coronary artery disease who presented with altered mental status and was found to have a persistently high troponin level resulting in three admissions to the coronary care unit for various noncardiac complaints. Because of discordance between clinical and laboratory data, immunological interference due to heterophile antibodies in the locally used assay (AccuTnI+3, Beckman Coulter) was suspected. The same serum sample tested on a different assay (Elecsys Troponin I Assay, Roche) resulted in an undetectable cardiac troponin I level, thus confirming the diagnosis.

Entities:  

Keywords:  Cardiac troponin; myocardial infarction; troponin immunoassay

Year:  2018        PMID: 29706818      PMCID: PMC5914466          DOI: 10.1080/08998280.2018.1440856

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN: 0899-8280


  15 in total

1.  Interferences in immunoassay--still a threat.

Authors:  L J Kricka
Journal:  Clin Chem       Date:  2000-08       Impact factor: 8.327

Review 2.  Biomarkers in acute cardiac disease: the present and the future.

Authors:  Allan S Jaffe; Luciano Babuin; Fred S Apple
Journal:  J Am Coll Cardiol       Date:  2006-06-12       Impact factor: 24.094

3.  Third universal definition of myocardial infarction.

Authors:  Kristian Thygesen; Joseph S Alpert; Allan S Jaffe; Maarten L Simoons; Bernard R Chaitman; Harvey D White
Journal:  Glob Heart       Date:  2012-09-26

4.  Troponin elevation in other conditions than acute coronary syndromes.

Authors:  Wafa Masri; Edouard Le Guillou; Eya Hamdi; Khaldoun Ghazal; Elise Lebigot; Claudine Cosson; Françoise Blonde Cynober; Patrice Therond
Journal:  Ann Biol Clin (Paris)       Date:  2017-08-01       Impact factor: 0.459

5.  Immunometric assay interference: incidence and prevention.

Authors:  Johan Bjerner; Kjell Nustad; Lars F Norum; Kari Hauge Olsen; Ole P Børmer
Journal:  Clin Chem       Date:  2002       Impact factor: 8.327

Review 6.  Troponin: the biomarker of choice for the detection of cardiac injury.

Authors:  Luciano Babuin; Allan S Jaffe
Journal:  CMAJ       Date:  2005-11-08       Impact factor: 8.262

Review 7.  Narrative review: alternative causes for elevated cardiac troponin levels when acute coronary syndromes are excluded.

Authors:  Allen Jeremias; C Michael Gibson
Journal:  Ann Intern Med       Date:  2005-05-03       Impact factor: 25.391

Review 8.  Human cardiac troponin complex. Structure and functions.

Authors:  I A Katrukha
Journal:  Biochemistry (Mosc)       Date:  2013-12       Impact factor: 2.487

9.  Equivalent early sensitivities of myoglobin, creatine kinase MB mass, creatine kinase isoform ratios, and cardiac troponins I and T for acute myocardial infarction.

Authors:  J Mair; D Morandell; N Genser; P Lechleitner; F Dienstl; B Puschendorf
Journal:  Clin Chem       Date:  1995-09       Impact factor: 8.327

10.  Alkaline phosphatase-immunoglobulin conjugate binds to lipids in vitro, independent of antibody selectivity.

Authors:  D Lingwood; J S Ballantyne
Journal:  J Immunol Methods       Date:  2006-02-28       Impact factor: 2.303

View more
  1 in total

1.  False-positive troponin I elevation in a newborn with neonatal encephalopathy.

Authors:  Elisabetta Caredda; Roberto Rosso; Carlo Capristo; Paolo Montaldo
Journal:  BMJ Case Rep       Date:  2019-05-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.